- Home
- Publications
- Publication Search
- Publication Details
Title
Features of Human CD3+CD20+T Cells
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 4, Pages 1111-1117
Publisher
The American Association of Immunologists
Online
2016-07-14
DOI
10.4049/jimmunol.1600089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- CD20+T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer
- (2015) Marco de Bruyn et al. OncoImmunology
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- CD3-Positive B Cells: A Storage-Dependent Phenomenon
- (2014) Angela Nagel et al. PLoS One
- Anti–B Cell Antibody Therapies for Inflammatory Rheumatic Diseases
- (2013) Mikkel Faurschou et al. Annual Review of Medicine
- A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
- (2013) Su-Hyun Kim et al. JAMA Neurology
- Memory T Cell Subsets, Migration Patterns, and Tissue Residence
- (2012) Scott N. Mueller et al. Annual Review of Immunology
- B cells in multiple sclerosis: connecting the dots
- (2011) H-Christian von Büdingen et al. CURRENT OPINION IN IMMUNOLOGY
- T Cell Receptor Internalization from the Immunological Synapse Is Mediated by TC21 and RhoG GTPase-Dependent Phagocytosis
- (2011) Nuria Martínez-Martín et al. IMMUNITY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects
- (2011) Paul Eggleton et al. ARTHRITIS RESEARCH & THERAPY
- CD3+CD20+ cells may be an artifact of flow cytometry: Comment on the article by Wilk et al
- (2010) Carole Henry et al. ARTHRITIS AND RHEUMATISM
- Pathogenic CD8+T cells in multiple sclerosis
- (2009) Manuel A. Friese et al. ANNALS OF NEUROLOGY
- Depletion of functionally active CD20+ T cells by rituximab treatment
- (2009) Esther Wilk et al. ARTHRITIS AND RHEUMATISM
- Peripheral T cells in the thymus: have they just lost their way or do they do something?
- (2009) Nabil Bosco et al. IMMUNOLOGY AND CELL BIOLOGY
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now